Company lists
The Texas edition · 2026

Life sciencescompanies in Texas

Oncology, genomics, platforms and tools, medical devices, startups and more: the companies building life sciences in Texas, with their founders, funding, team size and business models.

926 company profiles255 with recorded fundingNovember 2026 edition
Texas · Photo: Wikimedia Commons (CC BY-SA 3.0)

Recent life sciences business events in Texas

Funding, M&A, contract wins and launches involving 1,256 life sciences companies in Texas, last 24 months: 50 funding rounds · 36 M&A deals · 22 Contracts · 4 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: May 2026.

M&AAcquisition · Announced

Lilly acquires CrossBridge Bio

Lilly also has plans to buy Texas-based startup CrossBridge Bio, which is creating ADCs.

Biotech
FundingPrivate placement

CNS Pharmaceuticals

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) has announced a private placement expected to generate approximately $22.5 million in gross proceeds, according to a press release.

Investors ADAR1 Capital, Ikarian capital, Stonepine capital management, Nazare Partners
Biotechnology
M&AAcquisition · Pending

Allianz acquires Amprion

Later in March, AllianzGI signed an agreement to acquire an indirect stake in Amprion, Germany's second-largest electricity transmission system operator.

Electricity Transmission / Energy Infrastructure
M&AAcquisition · Announced

Eli Lilly and Company acquires CrossBridge Bio

Lilly is acquiring CrossBridge Bio (~$300M reported) to bolster oncology capabilities — diversifies growth beyond obesity/diabetes.

Biotechnology
LaunchWithZeta.ai

Lantern pharma

Lantern Pharma Inc. has announced the commercial launch of withZeta.ai, its multi-agentic AI co-scientist platform designed specifically for rare cancer drug discovery.

AI platform for rare cancer drug discovery
FundingSeries X Capital Investment

Verily

Dallas-based Verily has raised a new $300 million investment round led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz, and other…

Investors Series X Capital, Alphabet, Uchealth, University of Colorado Anschutz
Health technology / precision health AI
LaunchCEO Corner

Moleculin biotech

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced the launch of its CEO Corner, a new platform featuring Walter Klemp, Chief Executive Officer.

M&AAcquisition · Completed

CEC Liquid Telecom acquires Realtime

CEC Liquid Telecom announced that it had acquired Zambian ISP, Realtime, the country’s second largest ISP.

Internet Service Provider
FundingEquity investment

Castle biosciences

AIGH Capital Management LLC purchased a new stake in Castle Biosciences, Inc. in the 3rd quarter valued at approximately $16,105,000.

Investors AIGH Capital Management LLC, Amundi, Aqr capital management, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
LaunchAll‑paper containers (EOS brand)

Sonoco thermosafe

Traditional expanded polystyrene (EPS) is on the run, being replaced by all‑paper containers (designated as “curbside recyclable”) from Sonoco ThermoSafe (its EOS brand) and Truetemp…

Curable paper container
Contract

Sonoco thermosafe · client: Turkish airlines

Sonoco ThermoSafe, a temperature assurance packaging company, and Turkish Airlines, have signed a master lease agreement to offer Sonoco’s Pegasus unit load device (ULD)…

M&AAcquisition · Announced

Cypher Metaverse acquires Noninvasix

Cypher Metaverse Inc. (CSE:CODE.X) has announced a definitive agreement to acquire Noninvasix, Inc., creating a "Reverse Takeover" under Canadian Securities Exchange policies.

Metaverse
Contract

Noninvasix · client: Na

Noninvasix intends to complete an equity financing of units in its capital for minimum gross proceeds of US$3,000,000

Contract

Noninvasix · client: Accredited investors

"Noninvasix intends to complete an equity financing of units in its capital ('Noninvasix Units') for minimum gross proceeds of US$3,000,000 (the 'Noninvasix Private Placement')."

Technology
Contract

Cypher Metaverse · client: Noninvasix

"Cypher Metaverse Inc. (CSE:CODE.X) ('Cypher' or the 'Company') is pleased to announce that it has entered into an arms-length definitive agreement dated December 12, 2025 (the…

Technology
Funding

Curative

Curative – $150.0M

M&AMerger · Completed

Salarius pharmaceuticals acquires Decoy therapeutics

Salarius Pharmaceuticals, Inc. (NasdaqCM:SLRX) completed the acquisition of Decoy Therapeutics Inc. on November 12, 2025.

Pharmaceutical
FundingPublic offering

Savara

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the closing of its previously announced underwritten public…

Biopharmaceutical
FundingPublic offering

Savara

Savara sold to certain investors that so chose, pre-funded warrants to purchase 7,142,857 shares of common stock at a price of $4.199 per pre-funded warrant. The aggregate gross proceeds…

Biopharmaceutical
FundingDirect offering

Genprex

On October 28, 2025, Genprex, Inc. announced a securities purchase agreement for a registered direct offering of 377,780 shares of common stock at $9.00 per share, expected to close on…

Gene therapy
LaunchVerily Me

Verily

Dallas-based precision health AI company Verily has launched a new consumer health app, Verily Me.

Health App
FundingPublic offering

Actuate therapeutics

Actuate Therapeutics, Inc. (NASDAQ: ACTU) ("Actuate" or the "Company") ... the closing of its $17.25 million underwritten public offering of 2,464,286 shares of its common stock,…

Biopharmaceutical
M&AAcquisition · Announced

Apollo global management acquires Amprion

This operation provides for Apollo to acquire a 25.1 % stake in Amprion from RWE for EUR 3.2 billion.

Electricity transmission system operator
M&AAcquisition · Completed

Statlab medical products acquires Histoserve gmbh

StatLab Medical Products has completed the acquisitions of Germany-based Histoserve GmbH and Diapath France SAS, strengthening its direct sales presence in Europe’s top four pathology…

Histology service and distribution
M&AAcquisition · Completed

Statlab medical products acquires Diapath

In parallel, StatLab acquired the remaining stake in Diapath France—a joint venture formed in 2023 between Diapath and Jacques Hannaby to serve the direct laboratory market in France.

Direct Laboratory Market
FundingPrivate placement

Shattuck labs

Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily…

Investors Orbimed, A large healthcare-dedicated fund, Coastlands Capital, Prosight Capital
Biotechnology
Funding

Abeona therapeutics

Abeona Therapeutics took second place in the private biotech fundraising standings after it managed to raise $155 million by selling its U.S. Food and Drug Administration (FDA) priority…

Investors Undisclosed buyer
FundingPublic offering

Taysha gene therapies

May 2025 saw Taysha Gene Therapies bag the biggest public biotech investment of the month, with the company pricing a $200 million public offering. The company is focused on advancing…

Investors Na
Neurological

Life sciences companies in Texas, by funding and team

Few life sciences companies in Texas publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 926 active companies.

Showing 25 of 50

Developer of precision health platforms and solutions using artificial intelligence

Healthcare it
US$2.80bnSeries D · Mar 2026
1,103-2% vs previous recordLinkedIn · Oct 2026
E-commerce - product / Physical commerce
11 yr2015
0none in 3 months

Developer of panomic disease profiling technologies for cancer precision medicine

Genomics
US$1.23bnSeries D · Apr 2025
1,339recorded
Subscription
30 yr1996
—No postings tracked

Developing drugs and delivery system along with theranostic imaging primarily for CNS disorders

Life sciences platforms and tools
US$300.00mSeries D · Oct 2021
3LinkedIn · Jul 2026
E-commerce - product / Physical commerce
12 yr2014
—No postings tracked

Developer of drug-delivery solution for the treatment of pediatric wart treatment

Dermatology
US$262.71mSeries C · Oct 2025
50LinkedIn · Oct 2026
Fee-for-service
6 yr2020
0none in 3 months · last posted Jun 2026

Developer of a robotic system for endoluminal and single-incision surgery

Professional service robots
US$232.48mSeries D · May 2025
80+0% 12 mo to Dec 2021LinkedIn · Jul 2026
Physical commerce
9 yr2017
0none in 3 months

Developer of therapies to treat glaucoma and other diseases of the eye

Ophthalmology
US$209.80mSeries E · Sep 2013
6-71% 12 mo to Dec 2017LinkedIn · Oct 2026
E-commerce - product / Physical commerce
27 yr1999
0none in 3 months

Developer of neuromodulation therapy for neurological conditions

Neurology
US$179.95mSeries F · Mar 2025
239+120% 12 mo to Dec 2022LinkedIn · Jul 2026
Fee-for-service
19 yr2007
0none in 3 months · last posted May 2026

Developer of devices to lift the burden of heart failure

Cardiac and vascular disorders
US$179.87mSeries C · Dec 2024
58+19% vs previous recordLinkedIn · Jul 2026
E-commerce - product / Physical commerce
9 yr2017
0none in 3 months

Provider of therapeutics to treat kidney diseases

Metabolic diseases
US$168.51mSeries B · May 2023
31+0% vs previous recordLinkedIn · Jul 2026
Fee-for-service
13 yr2013
0none in 3 months

Developer of an immunotherapy platform for oncology and other diseases

Gastroenterology
US$165.40mSeries C · Jun 2020
55+51% 12 mo to Dec 2021LinkedIn · Oct 2026
Physical commerce
10 yr2016
0none in 3 months · last posted Jun 2026

Provider of self collecting COVID-19 testing centers listing platform

Infectious diseases
US$162.35mSeries B · Oct 2025
1,034+6153% 12 mo to Dec 2021LinkedIn · Oct 2026
Fee-for-service
6 yr2020
0none in 3 months

Developer of a device for organ preservation

Transplant medicine
US$151.67mSeries D · May 2025
20-27% vs previous recordLinkedIn · Jul 2026
Physical commerce
10 yr2016
0none in 3 months · last posted Apr 2026

Developer of T-cell therapies to treat infectious diseases

Life sciences platforms and tools
US$151.25mSeries B · May 2019
13+0% 12 mo to Dec 2022LinkedIn · Oct 2026
Fee-for-service
13 yr2013
0none in 3 months

Developer of a compound that exploits pH as a biomarker to diagnose and treat cancer

Oncology
US$137.97mSeries B · Apr 2025
22+0% 12 mo to Dec 2019LinkedIn · Jul 2026
Physical commerce
12 yr2014
0none in 3 months

Developer of T cell therapies for the treatment of cancer and chronic infectious diseases

Immunotherapy
US$137.53mSeries C · Sep 2014
18-33% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
22 yr2004
0none in 3 months

Provider of prescription lenses and solution for problems related to Digital Vision Syndrome

Ophthalmology
US$126.19mSeries E · Sep 2022
134LinkedIn · Jul 2026
Subscription
18 yr2008
0none in 3 months

Developer of gene-based therapies for treating CNS disorders

Neurology
US$125.00mSeries B · Aug 2020
140+115% vs previous recordLinkedIn · Oct 2026
Physical commerce
6 yr2020
0none in 3 months · last posted Oct 2024

Developer of a novel cancer therapy targeting Treg cells

Oncology
US$121.40mSeries C · Jul 2025
15LinkedIn · Jul 2026
Fee-for-service
23 yr2003
—No postings tracked

Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome

Cardiac and vascular disorders
US$114.35mSeries E · Feb 2024
27LinkedIn · Jul 2026
Physical commerce
21 yr2005
0none in 3 months

Developer of immunotherapeutics for the treatment of cancer

Oncology
US$110.76mSeries C · Apr 2025
15LinkedIn · Jul 2026
Subscription
7 yr2019
—No postings tracked

Platform offering CRM software for pharmacies

Sales force automation
US$106.50mSeries D · Mar 2019
90+87% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
16 yr2010
0none in 3 months

Provider of multiple diagnostics platforms for infectious diseases

Infectious diseases
US$105.29mSeries C · Jul 2025
77+35% 12 mo to Dec 2022LinkedIn · Jul 2026
Fee-for-service
10 yr2016
0none in 3 months

Speciality Company developing extended release drugs for CNS disorders using proprietary technology platform

Neurology
US$94.64mSeries D · Feb 2015
150-8% 12 mo to Jun 2023recorded Jun 2023
E-commerce - product / Physical commerce
18 yr2008
0none in 3 months

Provider of disinfection robots for multiple healthcare purposes

Hospital equipment
US$94.39mSeries D · Feb 2019
79-32% 12 mo to Dec 2022recorded Dec 2022
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months

Proivder of DNA test kits for dogs that enable dog owners to provide better pet care

Genomics
US$93.97mSeries B · Jul 2021
73LinkedIn · Oct 2026
Subscription
11 yr2015
0none in 3 months · last posted Oct 2025
50 of 926 companies shown here · the full list is on Radar
Fliar Radar

Explore all 926 life sciences companies in Texas on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in Texas on Radar
  • Every company, not just 50All 926 life sciences companies in Texas, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in Texas by what you are looking for

Find top life sciences companies in Texas across oncology, genomics, medical technology, and therapeutics. Explore life sciences companies in Texas by the science and care areas they serve.

7 ways to explore life sciences in Texas

Oncology & cancer treatment companiesGenomics & diagnostics companiesLife sciences platforms & laboratory toolsMedical devices & orthopedics companiesLife sciences startups in TexasLife sciences companies hiring in Texas

Oncology & cancer treatment companies

Companies developing cancer diagnostics, therapies, and research tools.

  1. Caris Life Sciences

    Developer of panomic disease profiling technologies for cancer precision medicine

    Genomics
    See in list
  2. OncoNano

    Developer of a compound that exploits pH as a biomarker to diagnose and treat cancer

    Oncology
    See in list
  3. Bellicum

    Developer of T cell therapies for the treatment of cancer and chronic infectious diseases

    Immunotherapy
    See in list
  4. CoRegen

    Developer of a novel cancer therapy targeting Treg cells

    Oncology
    See in list
  5. Tvardi

    Developer of small molecule based therapeutics for cancer treatment

    Oncology
    See in list

Genomics & diagnostics companies

Companies working with genetic data, testing, and clinical diagnostics.

  1. Caris Life Sciences

    Developer of panomic disease profiling technologies for cancer precision medicine

    Genomics
    See in list
  2. Bellicum

    Developer of T cell therapies for the treatment of cancer and chronic infectious diseases

    Immunotherapy
    See in list
  3. Embark Veterinary

    Proivder of DNA test kits for dogs that enable dog owners to provide better pet care

    Genomics
    See in list
  4. OncoVista

    Developer of therapeutics and diagnostics for cancer

    Genomics
    See in list
  5. Castle Biosciences

    Provider of diagnostic devices for treating cancer

    Dermatology
    See in list

Life sciences platforms & laboratory tools

Providers of laboratory technologies, research platforms, and scientific instruments.

  1. VUV Analytics

    Provider of vacuum ultraviolet absorption spectroscopic instruments

    Photonics
    See in list
  2. Ospribio

    Provider of molecular assays and laboratory building for medical facilities

    Life sciences platforms and tools
    Website
  3. Bioaffinity technologies

    Developer of IVD and targets cancer cells for therapeutics

    Life sciences platforms and tools
    Website
  4. BreviTest

    Developer of point of care diagnostic technology for automation of Enzyme Immunoassay

    Life sciences platforms and tools
    Website
  5. PAC

    Analytical lab instruments

    Life sciences platforms and tools
    Website

Medical devices & orthopedics companies

Companies building devices, implants, and equipment for care and surgery.

  1. MicroTransponder

    Developer of neuromodulation therapy for neurological conditions

    Neurology
    See in list
  2. Alleviant Medical

    Developer of devices to lift the burden of heart failure

    Cardiac and vascular disorders
    See in list
  3. Procyrion

    Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome

    Cardiac and vascular disorders
    See in list
  4. BiO2 Medical

    Innovating medical devices and biotechnology solutions for critical care and research

    Cardiac and vascular disorders
    See in list
  5. OsteoCentric

    Developer of orthopedic medical implants

    Orthopedics
    Website

Life sciences startups in Texas

Recently founded life sciences companies in Texas.

  1. March Biosciences

    Developer of CAR-T cell therapies for malignancies

    Oncology
    Website
  2. Autonomize

    AI-based drug discovery tool for researchers

    Life sciences tech
    Website
  3. Diakonos

    Provider of immunotherapeutics for cancer treatment

    Neurology
    Website
  4. MedScout

    Provider of sales enablement platform to life sciences companies

    Life sciences tech
    Website
  5. Form Bio

    Cloud-based data management tool for providers

    Life sciences tech
    Website
106 companies in Texas

Life sciences companies hiring in Texas

Life sciences companies in Texas with hiring activity.

  1. VeraDermics

    Developer of drug-delivery solution for the treatment of pediatric wart treatment

    Dermatology
    See in list
  2. MicroTransponder

    Developer of neuromodulation therapy for neurological conditions

    Neurology
    See in list
  3. Shattuck Labs

    Developer of an immunotherapy platform for oncology and other diseases

    Gastroenterology
    See in list
  4. Vascular Perfusion

    Developer of a device for organ preservation

    Transplant medicine
    See in list
  5. Taysha Gene Therapies

    Developer of gene-based therapies for treating CNS disorders

    Neurology
    See in list
20 companies in Texas

Public life sciences companies in Texas

Publicly listed life sciences companies in Texas.

  1. Caris Life Sciences

    Developer of panomic disease profiling technologies for cancer precision medicine

    Genomics
    See in list
  2. VeraDermics

    Developer of drug-delivery solution for the treatment of pediatric wart treatment

    Dermatology
    See in list
  3. Inotek Pharma

    Developer of therapies to treat glaucoma and other diseases of the eye

    Ophthalmology
    See in list
  4. Shattuck Labs

    Developer of an immunotherapy platform for oncology and other diseases

    Gastroenterology
    See in list
  5. Bellicum

    Developer of T cell therapies for the treatment of cancer and chronic infectious diseases

    Immunotherapy
    See in list
54 companies in Texas
Mobile reach

Top 10 life sciences apps from Texas

The most-installed Android apps published by life sciences companies headquartered in Texas — 588K installs between them. 24 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 10
2

Verily Me

by Verily

Installs113K
Rating4.41431 ratings
Last updatedMay 2026
View on Google Play ↗
Verily Me screenshot 1Verily Me screenshot 2Verily Me screenshot 3Verily Me screenshot 4Verily Me screenshot 5Verily Me screenshot 6
10

EVEXIAS Online

by EVEXIAS

Installs770
Rating—
Last updatedApr 2026
View on Google Play ↗
EVEXIAS Online screenshot 1EVEXIAS Online screenshot 2EVEXIAS Online screenshot 3EVEXIAS Online screenshot 4EVEXIAS Online screenshot 5EVEXIAS Online screenshot 6
RadarBrowse every life sciences company in Texas on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Texas compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, Texas36

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in Texas

28Acquisition
8Merger

Most active acquirers

  1. Statlab medical products3
  2. Endocare3
  3. Cypher Metaverse2
  4. Orthofix International2
  5. ILEX Oncology2

Most acquired or merged

  1. CrossBridge Bio2
  2. Amprion2
  3. Noninvasix2
  4. ILEX Oncology2
  5. Endocare2

Each deal appears in the events strip at the top of the page.

Go deeper in the life sciences landscape reports:

Life Sciences Industry Landscape of the United States
Industry landscape report

Life Sciences Industry Landscape of the United States

The financials above are one chapter. The full life sciences landscape of Texas maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of Texas

Life sciences funding in Texas

255 life sciences companies in Texas have recorded equity funding, US$10.89bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in Texas

Meet the people behind life sciences companies in Texas. 577 of 926 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Texas life sciences companies by sub-sector

The most common specialisations among life sciences companies in Texas. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in Texas

307 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in Texas

Browse the Radar directory

Coming soon